iCAN Science Meetup

You are still warmly invited to present your work as a poster.  Posters that have been presented previously are also accepted.

14.10 -15.30 Session I   Chair Satu Mustjoki

14.10 -14.40 Nina Mars: Germline polygenic risk across the cancer continuum: from somatic mutational signatures to prognosis

14.40 -15.30 Short talks based on abstracts

Arian Askari: Patient-derived conditionally reprogrammed cells for bladder cancer modeling and drug sensitivity assessment

Gantugs Atarsaikhan: Self-Supervised Learning for Pan-Cancer Tissue Profiling Using Multiplex Immunofluorescence Imaging

Salome Decombis: Bone marrow stromal cells impair natural killer (NK) cell activation and promote resistance of acute myeloid leukemia cells to NK cell cytotoxicity through cytokine signalling

Kalle Hokkanen: Simulation-driven precision epidemiology reveals that naïve penetrance severely underestimates lifetime cancer burden in MLH1 and MSH2, but not in MSH6 or PMS2, Lynch syndrome carriers

15.30 -16.00 Coffee break

16.00-17.25 Session II    Chair Tomi Mäkelä

16.00 – 16.30 Andrew Erickson: From Spatial Biology to the Clinic: Urine Single-Cell Based Prostate Cancer Diagnostics

16.30-17.05 Short talks based on abstracts

Mirte van der Heijden: The urine microbiome as a potential biomarker in cancer immunotherapy

Sara Palomino-Echeverria: Single-cell multi-omics profiling of High Grade Serous Ovarian Cancer reveals tumor phenotypes associated with clinical outcomes

Caroline Högel-Starck: Identifying epigenetic biomarkers for classification and therapeutic targeting of pediatric solid tumors

17.10 -17.25 Closing words: SIAB Chair Jonathan Knowles

17.25 -18.30 Poster session with refreshments, mingling and poster prizes

iCAN is part of the Research Council of Finland Flagship Programme with the University of Helsinki and HUS Helsinki University Hospital as founding partners.

Please get in touch:

ican@helsinki.fi

Follow us on social media:

© 2026 iCAN – Privacy Policy